Want to see GB:50GP full AI Analyst Report?
50GP Stock Chart & Stats
78.00 p
5.00 p(6.41%)
At close: 4:00 PM EDT
78.00 p
5.00 p(6.41%)
Day’s Range― - ―
52-Week Range78.00 p - 84.00 p
Previous CloseN/A
Volume302.46K
Average Volume (3M)0.00
Market Cap
£4.47B
Enterprise Value4.85B
Total Cash (Recent Filing)£205.30M
Total Debt (Recent Filing)£783.20M
Price to Earnings (P/E)56.7
Beta0.03
Next Earnings
Feb 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield702.38%
Share Statistics
EPS (TTM)0.57
Shares Outstanding616,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.00
Price to Book (P/B)1.72
Price to Sales (P/S)2.21
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthManageable leverage and broadly steady asset levels provide durable financial flexibility. A solid balance sheet supports ongoing capex for capacity, funds transformation initiatives, and preserves ability to sustain dividends or weather cyclical downturns without forcing distressed asset sales.
Cash Generation RecoveryA rebound in free cash flow alongside steady operating cash flow signals improved cash conversion and funding capacity. That strengthens the firm's ability to invest in growth, pay dividends and reduce net debt, making capital allocation more resilient over the coming 2–6 months.
Innovation-led Commercial TractionRapid growth of differentiated products (ceramides, Volufiline) demonstrates successful global commercialization and pricing power. Sustained innovation and brand-driven demand support higher-margin mix, repeat B2B orders and structural revenue diversification across end-markets.
Bears Say
Choppy Revenue & Declining Net IncomeMulti-year volatility in top-line and persistent deterioration in net income versus 2022 indicate weaker earnings power and margin pressure. Without sustained structural improvement, this trend can limit reinvestment, weaken return on capital, and constrain long-term EPS resilience.
Working-capital And Cash Conversion VolatilityLarge H1 working-capital outflows and net cash outflow after dividends reveal cash conversion volatility. Even with a program targeting structural WC savings, timing risk can strain liquidity and reduce predictable free cash flow in the medium term.
Exposure To Cyclical & Lumpy End-marketsDependence on lumpy Pharma projects and cyclical Crop Protection demand raises revenue and margin variability. Project phasing and agricultural cycles make forecasting and capacity utilization less predictable, increasing execution risk for margins and cash flow.
50GP FAQ
What was Croda International PLC’s price range in the past 12 months?
Croda International PLC lowest share price was 78.00 p and its highest was 84.00 p in the past 12 months.
What is Croda International PLC’s market cap?
Croda International PLC’s market cap is £4.47B.
When is Croda International PLC’s upcoming earnings report date?
Croda International PLC’s upcoming earnings report date is Feb 23, 2027 which is in 203 days.
How were Croda International PLC’s earnings last quarter?
Currently, no data Available
Is Croda International PLC overvalued?
According to Wall Street analysts Croda International PLC’s price is currently Overvalued.
Does Croda International PLC pay dividends?
Croda International PLC pays a Semiannually dividend of 2.95 p which represents an annual dividend yield of 702.38%. See more information on Croda International PLC dividends here
What is Croda International PLC’s EPS estimate?
Croda International PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Croda International PLC have?
Croda International PLC has 616,000 shares outstanding.
What happened to Croda International PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Croda International PLC?
Currently, no hedge funds are holding shares in GB:50GP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Croda International Stock Smart Score
Company Description
Croda International PLC
Croda International Plc is a global enterprise specializing in the development, manufacturing, and distribution of high-performance chemicals, with its market reach spanning Europe, the Middle East, Africa, North America, Asia, and Latin America. The company's operations are strategically organized across four main divisions: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. Croda's diverse product portfolio caters to numerous sectors. For agriculture, it provides solutions such as crop protection enhancers, seed treatment technologies, animal health compounds, bio-stimulants, and specialized additives for farming films. The industrial landscape benefits from its range of adhesives, lubricant components, protective coatings, polymer solutions, vehicle maintenance chemicals, and advanced additives for plastics, batteries, and catalysts, along with materials for automotive textiles and fibers. Within consumer care, Croda supplies essential ingredients for a broad spectrum of personal care applications, including skin, hair, sun, body, and baby care items, as well as components for cosmetics, deodorants, anti-perspirants, depilatories, men's grooming, and oral hygiene products. Its Life Sciences segment is a key supplier of active pharmaceutical ingredients, dietary supplements, and various health-related products. The company's expertise also extends to construction chemicals, bitumen additives, and specialized materials and polymer additives vital for electronics and devices. It offers chemistries, emulsifiers, fuel and power generation additives, and unique polymer additives designed for furniture and wood. Furthermore, Croda contributes to household, industrial, and institutional cleaning products, oleochemicals, and chemicals used in packaging, printing, and paper manufacturing, in addition to paints and coatings. A significant area of Croda's innovation lies in thermal management products and advanced bio-based phase change materials, which are critical for temperature control across varied applications, from buildings and apparel to healthcare, electronics, food refrigeration, energy storage, and automotive systems. Established in 1925, Croda International Plc maintains its headquarters in Goole, United Kingdom.



